Literature DB >> 3048316

TNF as an activator of vascular endothelium.

J S Pober1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3048316     DOI： 10.1016/0769-2625(88)90149-3

Source DB:  PubMed          Journal:  Ann Inst Pasteur Immunol        ISSN： 0769-2625


× No keyword cloud information.
  6 in total

Review 1.  Evaluation of TNF as antiviral, antibacterial and antiparasitic agent.

Authors:  G A Rook; J Taverne; J H Playfair
Journal:  Biotherapy       Date:  1991

Review 2.  Evidence that cytokines play a role in rheumatoid arthritis.

Authors:  Fionula M Brennan; Iain B McInnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

3.  Biological activity of mutants of human tumour necrosis factor-alpha.

Authors:  R Kircheis; J Milleck; V G Korobko; L N Shingarova; D Behnke; H E Schmidt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

Review 4.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

5.  Halothane potentiates the alcohol-adduct induced TNF-alpha release in heart endothelial cells.

Authors:  Geoffrey M Thiele; Gary E Hill; Jacqueline A Pavlik; Thomas L Freeman; Dean J Tuma; Michael J Duryee; Lynell W Klassen
Journal:  BMC Anesthesiol       Date:  2005-04-12       Impact factor: 2.217

6.  A novel miRNA-based classification model of risks and stages for clear cell renal cell carcinoma patients.

Authors:  Eskezeia Y Dessie; Jeffrey J P Tsai; Jan-Gowth Chang; Ka-Lok Ng
Journal:  BMC Bioinformatics       Date:  2021-05-25       Impact factor: 3.169
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.